Global Hereditary Angioedema Market Growth 2025-2031

October 2025 | 95 pages | ID: G783EEAD4D44EN
LP Information

Abstracts

The global Hereditary Angioedema market size is predicted to grow from US$ 1985 million in 2025 to US$ 3072 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the ?Hereditary Angioedema Industry Forecast? looks at past sales and reviews total world Hereditary Angioedema sales in 2024, providing a comprehensive analysis by region and market sector of projected Hereditary Angioedema sales for 2025 through 2031. With Hereditary Angioedema sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hereditary Angioedema industry.

This Insight Report provides a comprehensive analysis of the global Hereditary Angioedema landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hereditary Angioedema portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Hereditary Angioedema market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hereditary Angioedema and breaks down the forecast by Type, by Distribution Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hereditary Angioedema.

This report presents a comprehensive overview, market shares, and growth opportunities of Hereditary Angioedema market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• C1 Esterase Inhibitor
• Kallikrein Inhibitor
• Selective Bradykinin B2 Receptor Antagonist

Segmentation by Distribution Channel:

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pharming Group NV
• Takeda
• CSL Limited
• iBio Inc.
• BioCryst Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hereditary Angioedema market?
What factors are driving Hereditary Angioedema market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hereditary Angioedema market opportunities vary by end market size?
How does Hereditary Angioedema break out by Type, by Distribution Channel?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hereditary Angioedema Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Hereditary Angioedema by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Hereditary Angioedema by Country/Region, 2020, 2024 & 2031
2.2 Hereditary Angioedema Segment by Type
  2.2.1 C1 Esterase Inhibitor
  2.2.2 Kallikrein Inhibitor
  2.2.3 Selective Bradykinin B2 Receptor Antagonist
2.3 Hereditary Angioedema Sales by Type
  2.3.1 Global Hereditary Angioedema Sales Market Share by Type (2020-2025)
  2.3.2 Global Hereditary Angioedema Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Hereditary Angioedema Sale Price by Type (2020-2025)
2.4 Hereditary Angioedema Segment by Distribution Channel
  2.4.1 Retail Pharmacies
  2.4.2 Hospital Pharmacies
  2.4.3 Online Pharmacies
2.5 Hereditary Angioedema Sales by Distribution Channel
  2.5.1 Global Hereditary Angioedema Sale Market Share by Distribution Channel (2020-2025)
  2.5.2 Global Hereditary Angioedema Revenue and Market Share by Distribution Channel (2020-2025)
  2.5.3 Global Hereditary Angioedema Sale Price by Distribution Channel (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Hereditary Angioedema Breakdown Data by Company
  3.1.1 Global Hereditary Angioedema Annual Sales by Company (2020-2025)
  3.1.2 Global Hereditary Angioedema Sales Market Share by Company (2020-2025)
3.2 Global Hereditary Angioedema Annual Revenue by Company (2020-2025)
  3.2.1 Global Hereditary Angioedema Revenue by Company (2020-2025)
  3.2.2 Global Hereditary Angioedema Revenue Market Share by Company (2020-2025)
3.3 Global Hereditary Angioedema Sale Price by Company
3.4 Key Manufacturers Hereditary Angioedema Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Hereditary Angioedema Product Location Distribution
  3.4.2 Players Hereditary Angioedema Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR HEREDITARY ANGIOEDEMA BY GEOGRAPHIC REGION

4.1 World Historic Hereditary Angioedema Market Size by Geographic Region (2020-2025)
  4.1.1 Global Hereditary Angioedema Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Hereditary Angioedema Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hereditary Angioedema Market Size by Country/Region (2020-2025)
  4.2.1 Global Hereditary Angioedema Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Hereditary Angioedema Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hereditary Angioedema Sales Growth
4.4 APAC Hereditary Angioedema Sales Growth
4.5 Europe Hereditary Angioedema Sales Growth
4.6 Middle East & Africa Hereditary Angioedema Sales Growth

5 AMERICAS

5.1 Americas Hereditary Angioedema Sales by Country
  5.1.1 Americas Hereditary Angioedema Sales by Country (2020-2025)
  5.1.2 Americas Hereditary Angioedema Revenue by Country (2020-2025)
5.2 Americas Hereditary Angioedema Sales by Type (2020-2025)
5.3 Americas Hereditary Angioedema Sales by Distribution Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hereditary Angioedema Sales by Region
  6.1.1 APAC Hereditary Angioedema Sales by Region (2020-2025)
  6.1.2 APAC Hereditary Angioedema Revenue by Region (2020-2025)
6.2 APAC Hereditary Angioedema Sales by Type (2020-2025)
6.3 APAC Hereditary Angioedema Sales by Distribution Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Hereditary Angioedema by Country
  7.1.1 Europe Hereditary Angioedema Sales by Country (2020-2025)
  7.1.2 Europe Hereditary Angioedema Revenue by Country (2020-2025)
7.2 Europe Hereditary Angioedema Sales by Type (2020-2025)
7.3 Europe Hereditary Angioedema Sales by Distribution Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hereditary Angioedema by Country
  8.1.1 Middle East & Africa Hereditary Angioedema Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Hereditary Angioedema Revenue by Country (2020-2025)
8.2 Middle East & Africa Hereditary Angioedema Sales by Type (2020-2025)
8.3 Middle East & Africa Hereditary Angioedema Sales by Distribution Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hereditary Angioedema
10.3 Manufacturing Process Analysis of Hereditary Angioedema
10.4 Industry Chain Structure of Hereditary Angioedema

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Hereditary Angioedema Distributors
11.3 Hereditary Angioedema Customer

12 WORLD FORECAST REVIEW FOR HEREDITARY ANGIOEDEMA BY GEOGRAPHIC REGION

12.1 Global Hereditary Angioedema Market Size Forecast by Region
  12.1.1 Global Hereditary Angioedema Forecast by Region (2026-2031)
  12.1.2 Global Hereditary Angioedema Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hereditary Angioedema Forecast by Type (2026-2031)
12.7 Global Hereditary Angioedema Forecast by Distribution Channel (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Pharming Group NV
  13.1.1 Pharming Group NV Company Information
  13.1.2 Pharming Group NV Hereditary Angioedema Product Portfolios and Specifications
  13.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Pharming Group NV Main Business Overview
  13.1.5 Pharming Group NV Latest Developments
13.2 Takeda
  13.2.1 Takeda Company Information
  13.2.2 Takeda Hereditary Angioedema Product Portfolios and Specifications
  13.2.3 Takeda Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Takeda Main Business Overview
  13.2.5 Takeda Latest Developments
13.3 CSL Limited
  13.3.1 CSL Limited Company Information
  13.3.2 CSL Limited Hereditary Angioedema Product Portfolios and Specifications
  13.3.3 CSL Limited Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 CSL Limited Main Business Overview
  13.3.5 CSL Limited Latest Developments
13.4 iBio Inc.
  13.4.1 iBio Inc. Company Information
  13.4.2 iBio Inc. Hereditary Angioedema Product Portfolios and Specifications
  13.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 iBio Inc. Main Business Overview
  13.4.5 iBio Inc. Latest Developments
13.5 BioCryst Pharmaceuticals, Inc.
  13.5.1 BioCryst Pharmaceuticals, Inc. Company Information
  13.5.2 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Portfolios and Specifications
  13.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 BioCryst Pharmaceuticals, Inc. Main Business Overview
  13.5.5 BioCryst Pharmaceuticals, Inc. Latest Developments
13.6 Ionis Pharmaceuticals, Inc.
  13.6.1 Ionis Pharmaceuticals, Inc. Company Information
  13.6.2 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Portfolios and Specifications
  13.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Ionis Pharmaceuticals, Inc. Main Business Overview
  13.6.5 Ionis Pharmaceuticals, Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Hereditary Angioedema Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hereditary Angioedema Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of C1 Esterase Inhibitor
Table 4. Major Players of Kallikrein Inhibitor
Table 5. Major Players of Selective Bradykinin B2 Receptor Antagonist
Table 6. Global Hereditary Angioedema Sales by Type (2020-2025) & (K Units)
Table 7. Global Hereditary Angioedema Sales Market Share by Type (2020-2025)
Table 8. Global Hereditary Angioedema Revenue by Type (2020-2025) & ($ million)
Table 9. Global Hereditary Angioedema Revenue Market Share by Type (2020-2025)
Table 10. Global Hereditary Angioedema Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Hereditary Angioedema Sale by Distribution Channel (2020-2025) & (K Units)
Table 12. Global Hereditary Angioedema Sale Market Share by Distribution Channel (2020-2025)
Table 13. Global Hereditary Angioedema Revenue by Distribution Channel (2020-2025) & ($ million)
Table 14. Global Hereditary Angioedema Revenue Market Share by Distribution Channel (2020-2025)
Table 15. Global Hereditary Angioedema Sale Price by Distribution Channel (2020-2025) & (USD/Unit)
Table 16. Global Hereditary Angioedema Sales by Company (2020-2025) & (K Units)
Table 17. Global Hereditary Angioedema Sales Market Share by Company (2020-2025)
Table 18. Global Hereditary Angioedema Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Hereditary Angioedema Revenue Market Share by Company (2020-2025)
Table 20. Global Hereditary Angioedema Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Hereditary Angioedema Producing Area Distribution and Sales Area
Table 22. Players Hereditary Angioedema Products Offered
Table 23. Hereditary Angioedema Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Hereditary Angioedema Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Hereditary Angioedema Sales Market Share Geographic Region (2020-2025)
Table 28. Global Hereditary Angioedema Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Hereditary Angioedema Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Hereditary Angioedema Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Hereditary Angioedema Sales Market Share by Country/Region (2020-2025)
Table 32. Global Hereditary Angioedema Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Hereditary Angioedema Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Hereditary Angioedema Sales by Country (2020-2025) & (K Units)
Table 35. Americas Hereditary Angioedema Sales Market Share by Country (2020-2025)
Table 36. Americas Hereditary Angioedema Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Hereditary Angioedema Sales by Type (2020-2025) & (K Units)
Table 38. Americas Hereditary Angioedema Sales by Distribution Channel (2020-2025) & (K Units)
Table 39. APAC Hereditary Angioedema Sales by Region (2020-2025) & (K Units)
Table 40. APAC Hereditary Angioedema Sales Market Share by Region (2020-2025)
Table 41. APAC Hereditary Angioedema Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Hereditary Angioedema Sales by Type (2020-2025) & (K Units)
Table 43. APAC Hereditary Angioedema Sales by Distribution Channel (2020-2025) & (K Units)
Table 44. Europe Hereditary Angioedema Sales by Country (2020-2025) & (K Units)
Table 45. Europe Hereditary Angioedema Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Hereditary Angioedema Sales by Type (2020-2025) & (K Units)
Table 47. Europe Hereditary Angioedema Sales by Distribution Channel (2020-2025) & (K Units)
Table 48. Middle East & Africa Hereditary Angioedema Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Hereditary Angioedema Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Hereditary Angioedema Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Hereditary Angioedema Sales by Distribution Channel (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Hereditary Angioedema
Table 53. Key Market Challenges & Risks of Hereditary Angioedema
Table 54. Key Industry Trends of Hereditary Angioedema
Table 55. Hereditary Angioedema Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Hereditary Angioedema Distributors List
Table 58. Hereditary Angioedema Customer List
Table 59. Global Hereditary Angioedema Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Hereditary Angioedema Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Hereditary Angioedema Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Hereditary Angioedema Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Hereditary Angioedema Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Hereditary Angioedema Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Hereditary Angioedema Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Hereditary Angioedema Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Hereditary Angioedema Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Hereditary Angioedema Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Hereditary Angioedema Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Hereditary Angioedema Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Hereditary Angioedema Sales Forecast by Distribution Channel (2026-2031) & (K Units)
Table 72. Global Hereditary Angioedema Revenue Forecast by Distribution Channel (2026-2031) & ($ millions)
Table 73. Pharming Group NV Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 74. Pharming Group NV Hereditary Angioedema Product Portfolios and Specifications
Table 75. Pharming Group NV Hereditary Angioedema Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Pharming Group NV Main Business
Table 77. Pharming Group NV Latest Developments
Table 78. Takeda Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 79. Takeda Hereditary Angioedema Product Portfolios and Specifications
Table 80. Takeda Hereditary Angioedema Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Takeda Main Business
Table 82. Takeda Latest Developments
Table 83. CSL Limited Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Limited Hereditary Angioedema Product Portfolios and Specifications
Table 85. CSL Limited Hereditary Angioedema Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. CSL Limited Main Business
Table 87. CSL Limited Latest Developments
Table 88. iBio Inc. Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 89. iBio Inc. Hereditary Angioedema Product Portfolios and Specifications
Table 90. iBio Inc. Hereditary Angioedema Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. iBio Inc. Main Business
Table 92. iBio Inc. Latest Developments
Table 93. BioCryst Pharmaceuticals, Inc. Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 94. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Portfolios and Specifications
Table 95. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. BioCryst Pharmaceuticals, Inc. Main Business
Table 97. BioCryst Pharmaceuticals, Inc. Latest Developments
Table 98. Ionis Pharmaceuticals, Inc. Basic Information, Hereditary Angioedema Manufacturing Base, Sales Area and Its Competitors
Table 99. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Portfolios and Specifications
Table 100. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Ionis Pharmaceuticals, Inc. Main Business
Table 102. Ionis Pharmaceuticals, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Hereditary Angioedema
Figure 2. Hereditary Angioedema Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hereditary Angioedema Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Hereditary Angioedema Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hereditary Angioedema Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hereditary Angioedema Sales Market Share by Country/Region (2024)
Figure 10. Hereditary Angioedema Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of C1 Esterase Inhibitor
Figure 12. Product Picture of Kallikrein Inhibitor
Figure 13. Product Picture of Selective Bradykinin B2 Receptor Antagonist
Figure 14. Global Hereditary Angioedema Sales Market Share by Type in 2025
Figure 15. Global Hereditary Angioedema Revenue Market Share by Type (2020-2025)
Figure 16. Hereditary Angioedema Consumed in Retail Pharmacies
Figure 17. Global Hereditary Angioedema Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 18. Hereditary Angioedema Consumed in Hospital Pharmacies
Figure 19. Global Hereditary Angioedema Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 20. Hereditary Angioedema Consumed in Online Pharmacies
Figure 21. Global Hereditary Angioedema Market: Online Pharmacies (2020-2025) & (K Units)
Figure 22. Global Hereditary Angioedema Sale Market Share by Distribution Channel (2024)
Figure 23. Global Hereditary Angioedema Revenue Market Share by Distribution Channel in 2025
Figure 24. Hereditary Angioedema Sales by Company in 2025 (K Units)
Figure 25. Global Hereditary Angioedema Sales Market Share by Company in 2025
Figure 26. Hereditary Angioedema Revenue by Company in 2025 ($ millions)
Figure 27. Global Hereditary Angioedema Revenue Market Share by Company in 2025
Figure 28. Global Hereditary Angioedema Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Hereditary Angioedema Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Hereditary Angioedema Sales 2020-2025 (K Units)
Figure 31. Americas Hereditary Angioedema Revenue 2020-2025 ($ millions)
Figure 32. APAC Hereditary Angioedema Sales 2020-2025 (K Units)
Figure 33. APAC Hereditary Angioedema Revenue 2020-2025 ($ millions)
Figure 34. Europe Hereditary Angioedema Sales 2020-2025 (K Units)
Figure 35. Europe Hereditary Angioedema Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Hereditary Angioedema Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Hereditary Angioedema Revenue 2020-2025 ($ millions)
Figure 38. Americas Hereditary Angioedema Sales Market Share by Country in 2025
Figure 39. Americas Hereditary Angioedema Revenue Market Share by Country (2020-2025)
Figure 40. Americas Hereditary Angioedema Sales Market Share by Type (2020-2025)
Figure 41. Americas Hereditary Angioedema Sales Market Share by Distribution Channel (2020-2025)
Figure 42. United States Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Hereditary Angioedema Sales Market Share by Region in 2025
Figure 47. APAC Hereditary Angioedema Revenue Market Share by Region (2020-2025)
Figure 48. APAC Hereditary Angioedema Sales Market Share by Type (2020-2025)
Figure 49. APAC Hereditary Angioedema Sales Market Share by Distribution Channel (2020-2025)
Figure 50. China Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 54. India Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Hereditary Angioedema Sales Market Share by Country in 2025
Figure 58. Europe Hereditary Angioedema Revenue Market Share by Country (2020-2025)
Figure 59. Europe Hereditary Angioedema Sales Market Share by Type (2020-2025)
Figure 60. Europe Hereditary Angioedema Sales Market Share by Distribution Channel (2020-2025)
Figure 61. Germany Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 62. France Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Hereditary Angioedema Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Hereditary Angioedema Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Hereditary Angioedema Sales Market Share by Distribution Channel (2020-2025)
Figure 69. Egypt Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Hereditary Angioedema Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Hereditary Angioedema in 2025
Figure 75. Manufacturing Process Analysis of Hereditary Angioedema
Figure 76. Industry Chain Structure of Hereditary Angioedema
Figure 77. Channels of Distribution
Figure 78. Global Hereditary Angioedema Sales Market Forecast by Region (2026-2031)
Figure 79. Global Hereditary Angioedema Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Hereditary Angioedema Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Hereditary Angioedema Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Hereditary Angioedema Sales Market Share Forecast by Distribution Channel (2026-2031)
Figure 83. Global Hereditary Angioedema Revenue Market Share Forecast by Distribution Channel (2026-2031)